Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Takeda swoops in to buy stem cell partner TiGenix for $630M, putting it on the threshold of a likely approval
Takeda swoops in to buy stem cell partner TiGenix for $630M, putting it on the threshold of a likely approval
Takeda swoops in to buy stem cell partner TiGenix for $630M, putting it on the threshold of a likely approval
Submitted by
admin
on January 5, 2018 - 10:05am
Source:
Endpoints
News Tags:
Takeda
TiGenix
M&A
Crohn’s disease
gene therapy
Cx601
Headline:
Takeda swoops in to buy stem cell partner TiGenix for $630M, putting it on the threshold of a likely approval
Do Not Allow Advertisers to Use My Personal information
